Ali  Keshavarzian  to  Parkinson Disease
                            
                            
                                This is a "connection" page, showing publications  Ali  Keshavarzian  has written about  Parkinson Disease.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            5.107
         
        
        
     
 
    
        
        - 
            Overview of the Gut-Brain Axis: From Gut to Brain and Back Again. Semin Neurol. 2023 08; 43(4):506-517.
            
            
                Score: 0.514
             
- 
            An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants. Nat Commun. 2023 02 18; 14(1):926.
            
            
                Score: 0.497
             
- 
            Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis. Int Rev Neurobiol. 2022; 167:81-99.
            
            
                Score: 0.481
             
- 
            Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780.
            
            
                Score: 0.473
             
- 
            Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1. Curr Neurol Neurosci Rep. 2022 07; 22(7):335-342.
            
            
                Score: 0.473
             
- 
            The gut microbiome in Parkinson's disease: A culprit or a bystander? Prog Brain Res. 2020; 252:357-450.
            
            
                Score: 0.405
             
- 
            Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Neurobiol Dis. 2020 02; 135:104352.
            
            
                Score: 0.373
             
- 
            Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019 05; 68(5):829-843.
            
            
                Score: 0.372
             
- 
            Colonic bacterial composition in Parkinson's disease. Mov Disord. 2015 Sep; 30(10):1351-60.
            
            
                Score: 0.294
             
- 
            Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One. 2011; 6(12):e28032.
            
            
                Score: 0.229
             
- 
            Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023 03; 38(3):399-409.
            
            
                Score: 0.124
             
- 
            A prebiotic diet modulates microglial states and motor deficits in a-synuclein overexpressing mice. Elife. 2022 11 08; 11.
            
            
                Score: 0.122
             
- 
            Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathol Commun. 2021 08 19; 9(1):139.
            
            
                Score: 0.112
             
- 
            Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun. 2019 01 18; 10(1):310.
            
            
                Score: 0.094
             
- 
            Gut bacterial composition in a mouse model of Parkinson's disease. Benef Microbes. 2018 Sep 18; 9(5):799-814.
            
            
                Score: 0.091
             
- 
            The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies. Eur J Pharmacol. 2017 Dec 15; 817:86-95.
            
            
                Score: 0.084
             
- 
            Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet. Nutr Neurosci. 2018 Jul; 21(6):391-402.
            
            
                Score: 0.082
             
- 
            Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease. Cell. 2016 Dec 01; 167(6):1469-1480.e12.
            
            
                Score: 0.081
             
- 
            Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014 Jul; 29(8):999-1009.
            
            
                Score: 0.065
             
- 
            Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord. 2012 May; 27(6):716-9.
            
            
                Score: 0.059
             
- 
            Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord. 2012 May; 27(6):709-15.
            
            
                Score: 0.056
             
- 
            Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol. 2020 10 20; 18(1):137.
            
            
                Score: 0.026